EverImmune
Development of live biotherapeutic products in the field of microbiota oncology.
Villejuif, Francewww.everimmune.com ↗
Total raised
€8.8M
€8,778,069
Funding rounds
2
Investors
2
distinct backers
Active since
2021-11
latest 2023-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-19 | Other | €3.5M | Bpifrance | View deal → |
| 2021-11-30 | Series A | €5.3M | Private Investors | View deal → |
Investors
2Related news
- EverImmune Raises €5M in Series A Fundingfinsmes.com · 2021-11
- tech.eu
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software